GEVO Form 144: Insider Notice to Sell 1,530 Shares ($2,493)

Gevo, Inc. Form 144 summary: An insider filing discloses a proposed sale of 1,530 shares of Gevo common stock through Stifel Nicolaus & Company Inc. with an aggregate market value of $2,493.00, and an approximate sale date of 09/04/2025.

Rhea-AI Filing Summary

Gevo, Inc. Form 144 summary: An insider filing discloses a proposed sale of 1,530 shares of Gevo common stock through Stifel Nicolaus & Company Inc. with an aggregate market value of $2,493.00, and an approximate sale date of 09/04/2025. The filing reports the securities were acquired as restricted stock units on 09/03/2025 and payment is indicated as cash on 09/04/2025. The filing lists total shares outstanding as 239,562,995. The filer previously sold 12,370 shares on 08/05/2025 (gross proceeds $15,223.00) and 11,694 shares on 08/01/2025 (gross proceeds $14,651.00).

Insights

Financial Analyst

TL;DR: Small insider sale disclosed; amounts are immaterial relative to outstanding shares and show routine disposition of recently vested RSUs.

The filing shows a proposed sale of 1,530 shares valued at $2,493 and two recent sales in August totaling 24,064 shares for roughly $29,874. The shares to be sold were acquired as restricted stock units one day prior to the proposed sale, indicating a rapid disposition of vested awards. Given the issuer's reported 239,562,995 shares outstanding, the proposed sale is immaterial to capitalization. This disclosure is relevant for transparency but unlikely to move valuation.

Compliance/Risk Analyst

TL;DR: Filing appears to meet Rule 144 disclosure requirements; no undisclosed material information indicated in the notice.

The filer represents no knowledge of material non-public information and provides transaction dates, acquisition method (RSUs), broker details (Stifel Nicolaus), and past three months' sales. Dates and broker are specified, which supports compliance with Rule 144 notice obligations. The rapid sale after acquisition suggests the filer relied on available sale conditions; the form contains the mandatory attestations required by the rule.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction does the GEVO Form 144 disclose?

The filing discloses a proposed sale of 1,530 shares of Gevo common stock with aggregate market value $2,493.00 through Stifel Nicolaus & Company Inc., approx. sale date 09/04/2025.

How were the shares acquired that are to be sold according to the filing?

The shares were acquired as restricted stock units (RSUs) on 09/03/2025 and payment is listed as cash on 09/04/2025.

What prior insider sales are reported in the Form 144 for GEVO?

The filing reports two sales: 12,370 shares on 08/05/2025 (gross proceeds $15,223.00) and 11,694 shares on 08/01/2025 (gross proceeds $14,651.00).

Who is the broker identified for the proposed sale in the GEVO Form 144?

The broker named is Stifel Nicolaus & Company Inc, address listed as 501 N Broadway St. Louis MO 63102.

How many shares outstanding does the filing report for Gevo?

The filing lists 239,562,995 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/04/2025 - 04:48 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001866673
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Gevo, Inc.
SEC File Number	001-35073
Address of Issuer	345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD COLORADO 80112
Phone	303-858-8358
Name of Person for Whose Account the Securities are To Be Sold	Bowron Kimberly T
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	1530	2493.00	239562995	09/04/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/03/2025	Restricted Stock Units	Issuer			3333	09/04/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kimberly Bowron 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/05/2025	12370	15223.00
Kimberly Bowron 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/01/2025	11694	14651.00

144: Remarks and Signature

Remarks
Date of Notice	09/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Kimberly Bowron
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)